Literature DB >> 18625225

PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma.

Chaochen Wang1, Ying Xiao, Zhonghua Hu, Yibin Chen, Na Liu, Gengxi Hu.   

Abstract

PEG10 is an imprinted gene which is up-regulated in hepatocelluar carcinoma (HCC). However, the mechanism of PEG10 regulation remains to be elucidated. In this work the transcription factors E2F-1 and -4 were demonstrated to bind directly to the promoter of PEG10 and thereby regulate its expression. The expression profile of HCC tissues also suggested E2Fs were involved in PEG10 regulation. Further functional analysis showed that PEG10 was involved in the repression of apoptosis induced by serum deprivation and chemotherapeutic drugs. These findings link cancer genetics and epigenetics by showing that E2F acts directly upstream of an anti-apoptosis imprinted gene, PEG10.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625225     DOI: 10.1016/j.febslet.2008.07.009

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Dynamic expression patterns of imprinted genes in human embryonic stem cells following prolonged passaging and differentiation.

Authors:  Xiuyun Mai; Qingyun Mai; Tao Li; Canquan Zhou
Journal:  J Assist Reprod Genet       Date:  2010-12-16       Impact factor: 3.412

2.  E2F transcription factors and digestive system malignancies: how much do we know?

Authors:  Konstantinos Evangelou; Sophia Havaki; Athanassios Kotsinas
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 3.  E2F transcription factors and digestive system malignancies: how much do we know?

Authors:  Athanasios Xanthoulis; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

4.  Functional analysis of LOXL2 in pancreatic carcinoma.

Authors:  Felix Rückert; Peer Joensson; Hans-Detlev Saeger; Robert Grützmann; Christian Pilarsky
Journal:  Int J Colorectal Dis       Date:  2009-12-09       Impact factor: 2.571

5.  Phosphorylated E2F1 is stabilized by nuclear USP11 to drive Peg10 gene expression and activate lung epithelial cells.

Authors:  Dan Wang; Jing Zhao; Shuang Li; Jianxin Wei; Ling Nan; Rama K Mallampalli; Nathaniel M Weathington; Haichun Ma; Yutong Zhao
Journal:  J Mol Cell Biol       Date:  2018-02-01       Impact factor: 6.216

6.  PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma.

Authors:  Fengjie Liu; Yumei Gao; Bufang Xu; Shan Xiong; Shengguo Yi; Jingru Sun; Zhuojing Chen; Xiangjun Liu; Yingyi Li; Yuchieh Lin; Yujie Wen; Yao Qin; Shuxia Yang; Hang Li; Trilokraj Tejasvi; Lam Tsoi; Ping Tu; Xianwen Ren; Yang Wang
Journal:  Blood       Date:  2022-01-27       Impact factor: 22.113

7.  Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma.

Authors:  Heejin Bang; Sang Yun Ha; Soo Hyun Hwang; Cheol-Keun Park
Journal:  Cancer Res Treat       Date:  2015-02-13       Impact factor: 4.679

8.  Genetic and molecular analyses of PEG10 reveal new aspects of genomic organization, transcription and translation.

Authors:  Heike Lux; Heiko Flammann; Mathias Hafner; Andreas Lux
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

9.  The direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis.

Authors:  Vita M Golubovskaya; Min Zheng; Li Zhang; Jian-Liang Li; William G Cance
Journal:  BMC Cancer       Date:  2009-08-12       Impact factor: 4.430

Review 10.  Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy?

Authors:  P Meng; R Ghosh
Journal:  Cell Death Dis       Date:  2014-08-07       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.